Paper526754
The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].
Bateman DN and 3 others. Br J Pharmacol, 1979. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings]. Papers, record 526754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526754
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dyskinesia, Drug-Induced | Major topic |
| Haloperidol | Major topic |
| Metoclopramide | Major topic |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 82,759 | Extrapyramidal side-effects of metoclopramide. | Lancet | 1978 | https://conductscience.org/library/papers/82759 | PubMed |
| 2 | 620,205 | Tardive dyskinesia associated with metoclopramide. | Br Med J | 1978 | https://conductscience.org/library/papers/620205 | PubMed |
| 3 | 127,927 | The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias). | Mod Trends Neurol | 1975 | https://conductscience.org/library/papers/127927 | PubMed |
| 4 | 239,122 | Cardiovascular dopamine receptor stimulation antagonized by metoclopramide. | J Pharm Pharmacol | 1975 | https://conductscience.org/library/papers/239122 | PubMed |
| 5 | 4,938,431 | Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. | Br Med J | 1971 | https://conductscience.org/library/papers/4938431 | PubMed |
| 6 | 1,239,323 | Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content. | Br J Pharmacol | 1975 | https://conductscience.org/library/papers/1239323 | PubMed |
| 7 | 5,845,210 | [Clinical and electroencephalographic effects of methoclopramide in psychiatry]. | Therapie | 1965 | https://conductscience.org/library/papers/5845210 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29,409,162 | Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29409162 | PubMed |
| 29,342,497 | Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29342497 | PubMed |
| 16,437,531 | Antipsychotic medication for elderly people with schizophrenia. | Cochrane Database Syst Rev | 2006 | https://conductscience.org/library/papers/16437531 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/526754
GET https://conductscience.org/api/papers/v1/526754/authors